YanJinMD

PubMed

• 1 citations
  Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee os...
  Claire Smith, Y. Jin, Eyas Raddad, Terry A. McNearney, Xiao Ni, David Monteith, Roger Brown, Mark A. Deeg, Thomas J. Schnitzer> ;Pharmaceutical Statistics. 2019 Jan 1
• Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
  Kreutz, R. P.,Bitar, A.,Owens, J.,Desta, Z.,Breall, J. A.,von der Lohe, E.,Sinha, A.,Vatta, M.,Nystrom, P.,Jin, Y.,Flockhart, D. A.> ;J. Thromb. Thrombolysis. 2014 Feb 11
• Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response.
  Kreutz, R. P., Nystrom, P., Kreutz, Y., Miao, J., Desta, Z., Breall, J. A., Li, L., Chiang, C., Kovacs, R., Flockhart, D. A., Jin, Y.> ;Clin Pharmacol. 2012
• Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.
  Kreutz, R. P.,Nystrom, P.,Kreutz, Y.,Miao, J.,Kovacs, R.,Desta, Z.,Flockhart, D. A.,Jin, Y.> ;Platelets. 2013
• Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
  Jin, Y.,Hayes, D. F.,Li, L.,Robarge, J. D.,Skaar, T. C.,Philips, S.,Nguyen, A.,Schott, A.,Hayden, J.,Lemler, S.,Storniolo, A. M.,Flockhart, D. A.,Stearns, V.> ;J. Clin. Oncol.. 2008 Nov 20
• Molecular genetic analysis of interleukin-1 promoter and receptor antagonist tandem repeat polymorphisms among HLA-identical renal transplant recipient and donor pairs.
  Jin, Y.,Ruiz, P.> ;Transplant. Proc.. 2008 Jul 01
• Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response.
  Kreutz, R. P.,Owens, J.,Jin, Y.,Nystrom, P.,Desta, Z.,Kreutz, Y.,Breall, J. A.,Li, L.,Chiang, C.,Kovacs, R. J.,Flockhart, D. A.> ;Clin Pharmacol. 2013 Dec 20
• Join now to see all